In the livers of HFD-induced NAFLD rats, selenium supplementation recovered dyslipidemia and improved liver function and hepatic steatosis by activating Ppar-α expression and subsequently elevating fatty acid oxidation [126]. The gene discussed is PPARA; the disease is fatty liver disease.